Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$191.17 - $325.63 $4,396 - $7,489
23 Added 1.33%
1,758 $572,000
Q4 2023

Feb 08, 2024

BUY
$160.99 - $215.69 $1,287 - $1,725
8 Added 0.46%
1,735 $330,000
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $335,607 - $490,416
1,727 New
1,727 $343,000
Q1 2022

May 17, 2022

SELL
$127.96 - $207.36 $320,411 - $519,229
-2,504 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $413,485 - $605,542
2,504 New
2,504 $447,000
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $409,975 - $588,925
-2,500 Closed
0 $0
Q2 2021

Aug 17, 2021

BUY
$131.45 - $201.49 $328,625 - $503,725
2,500 New
2,500 $474,000
Q1 2021

May 18, 2021

SELL
$92.73 - $142.05 $231,825 - $355,125
-2,500 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $168,600 - $259,300
2,500 New
2,500 $259,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.